The US Food and Drug Administration (FDA) has granted accelerated approval for Ireland-headquartered Jazz Pharmaceuticals’ ...

Swiss generics and biosimilar major Sandoz today presented its financial results for the first half of 2025. and reiterated ...

Merck & Co (NYSE: MRK) was the biggest spender in pharma M&A during July. The US pharma giant boldly splashed out around $10 ...

Hungary’s largest drugmaker Gedeon Richter has announced its financial results for the second quarter and first half year of 2025.

Denmark’s Novo Nordisk saw its shares fall 4.8% to 291.20 kroner by early afternoon, after it posted financials results for ...

Germany’s Bayer experienced a nightmare day’s trading Wednesday, with shares in the life sciences company more than 8% lower ...

The US Food and Drug Administration (FDA) has approved an expanded indication of the intravenous (IV) formulation of South ...

Biologics-focused contract manufacturing and research organization Abenza announced that Geoffrey Glass has been appointed ...

Pharmaceutical regulation is undergoing its biggest shake-up in decades. On both sides of the Atlantic, policymakers are ...

Further evidence that US Department of Health and Human Services (HHS) secretary Robert F Kennedy Junior (RFK Jr) is willing ...

US specialty pharma business SERB Pharmaceuticals is acquiring Y-mAbs Therapeutics (Nasdaq: YMAB) in a $412 million all-cash ...

Japanese drugmaker Nxera Pharma has unveiled a slate of new programs targeting obesity and related metabolic diseases, ...